michigan glp-1 intestinal paralysis class action While many patients are seeing life-changing results with medications, doctors say the medications can also come with risks if they are not dosed properly. (Photo: AP Photo/David J. Phillip, File) 🦷🐟 Deep sea science, real-world

This foundational discovery later recognized with the 2024 LaskerDeBakey Clinical Medical Research Award for Habener, Mojsov, and Lotte Bjerre Knudsen laid the foundation for an entirely new class of GLP-1 medications.[1] Gut releases natural GLP-1 that is destroyed in the bloodstream within about two minutes by the enzyme DPP-4 that is a widely distributed integral membrane protein that is expressed in the intestine, kidney, vascular endothelium, liver pancreas, glandular epithelial cells, and immune system cells.[17] Hence, DPP-4 inhibitors are a successful class of anti-hyperglycaemic agents used to treat type 2 diabetes (T2DM) via protecting GLP-1

Microbial cause of ICU-acquired pneumonia: Hospital-acquired pneumonia versus ventilator-associated pneumonia

Ayusha Khan has completed a dermatology observership at Queen Elizabeth Hospital, Birmingham (UK)

Ohio State Health & Discovery